Latest filing published 15 Mar 2011 for Molecular Templates, Inc., €18k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
John G. Curd: trading record in brief
John G. Curd is a declared insider at 2 companies; the most frequent names are Paratek Pharmaceuticals, Inc. and Molecular Templates, Inc. We count 166 filings; the first trade dates from 15 May 2006 and the latest from 11 March 2011.
In open-market terms, that means 23 purchases worth €146k on one side and 137 sales worth €488k on the other. The totals exclude 10 filings filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 5 option exercises. So far in 2011, the count stands at 1 purchase and no sales.
Half of the purchases are above €2,363 and half below.
On 15 March 2011 came the latest disclosure, an open-market purchase for €18k in Molecular Templates, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to John G. Curd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 11,904 shares@ US$2.10Common StockSEC:0001181431-11-018228:0Canonical exit: 9 Jun 2011 (T+90)
- 5,000 shares@ US$2.83Common StockSEC:0001181431-09-049902:0Canonical exit: 31 Jan 2010 (T+90)
- 26,178 shares@ US$1.86Common StockSEC:0001181431-09-047067:0Canonical exit: 3 Jan 2010 (T+90)
- 5,000 shares@ US$1.83Common StockSEC:0001181431-09-046902:0Canonical exit: 30 Dec 2009 (T+90)
- 5,000 shares@ US$1.53Common StockSEC:0001181431-09-042187:0Canonical exit: 30 Nov 2009 (T+90)
- 5,000 shares@ US$1.59Common StockSEC:0001181431-09-037462:0Canonical exit: 1 Nov 2009 (T+90)
- 5,000 shares@ US$1.50Common StockSEC:0001181431-09-033601:0Canonical exit: 29 Sept 2009 (T+90)
- 5,000 shares@ US$1.49Common StockSEC:0001181431-09-028902:0Canonical exit: 1 Sept 2009 (T+90)
- 5,000 shares@ US$1.27Common StockSEC:0001181431-09-018537:0Canonical exit: 30 Jun 2009 (T+90)
- 5,000 shares@ US$1.07Common StockSEC:0001181431-09-013524:0Canonical exit: 1 Jun 2009 (T+90)
- 5,000 shares@ US$0.6234Common StockSEC:0001181431-09-004859:0Canonical exit: 26 Apr 2009 (T+90)
- 5,000 shares@ US$0.4482Common StockSEC:0001181431-08-059126:0Canonical exit: 27 Jan 2009 (T+90)
- 24,509 shares@ US$2.04Common StockSEC:0001181431-08-051363:0Canonical exit: 27 Nov 2008 (T+90)
- 5,000 shares@ US$0.39Common StockSEC:0001181431-08-043522:0Canonical exit: 14 Oct 2008 (T+90)
- 5,000 shares@ US$0.369Common StockSEC:0001181431-08-020567:0Canonical exit: 18 Jun 2008 (T+90)
- 5,000 shares@ US$0.418Common StockSEC:0001181431-08-006813:0Canonical exit: 30 Apr 2008 (T+90)
- 1,100 shares@ US$0.6472Common StockSEC:0001181431-07-075937:0Canonical exit: 13 Mar 2008 (T+90)
- 3,900 shares@ US$0.65Common StockSEC:0001181431-07-075937:1Canonical exit: 13 Mar 2008 (T+90)
- 1,000 shares@ US$0.61Common StockSEC:0001181431-07-072829:0Canonical exit: 2 Mar 2008 (T+90)
- 4,000 shares@ US$0.606Common StockSEC:0001181431-07-072829:1Canonical exit: 2 Mar 2008 (T+90)
- 200 shares@ US$0.5601Common StockSEC:0001181431-07-070628:0Canonical exit: 14 Feb 2008 (T+90)
- 3,600 shares@ US$0.57Common StockSEC:0001181431-07-070628:1Canonical exit: 14 Feb 2008 (T+90)
- 1,200 shares@ US$0.58Common StockSEC:0001181431-07-070628:2Canonical exit: 14 Feb 2008 (T+90)
- 400 shares@ US$11.04Common Stock, par value $0.001SEC:0001181431-07-036891:0
- 100 shares@ US$11.05Common Stock, par value $0.001SEC:0001181431-07-036891:1
25 of 121 declarations
